Atlas Molecular Pharma
Riccardo obtained a Master Degree in Pharmaceutical Biotechnology at University of Padua. He is currently doing a PhD in Atlas Molecular Pharma, focusing on the characterization of ligand-protein interaction with the aim of developing a Pharmacological Chaperon for the treatment of Tyrosinemia type I.
This person is not in any offices
Atlas Molecular Pharma
Atlas Molecular Pharma is focused on the discovery of first-in-class, innovative therapeutics for the treatment of patients.